Art Leader critiques the Assisted Human Reproduction Act draft regulations and maintains that the Act fails to address societal challenges relating to emerging reproductive science.

Sally Bean summarizes the recent expert report on Medical Assistance in Dying in Canada and suggests that a legislative amendment is unlikely until compelling evidence exists or a common law ruling requires it.

Kathy Hodgkinson and Daryl Pullman propose that high risk/high recurrence genetic diseases should come under the purview of public health.

Françoise Baylis responds to the recently announced birth of the world’s first genome edited babies and raises concerns about the scientific practice and ethical accountability.

Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.

Jason Scott Robert suggests that the creation of part-human animals in stem cell biology may generate scientific confusion.

Yeyang Su invites Impact Ethics readers to mark their calendars for the second International Summit on Human Genome Editing.